Genesis Therapeutics

Genesis Therapeutics pairs proven drug developers with the industry's most advanced small molecule discovery platform to accelerate and optimize the development of new drugs. Leading academic research forms the initial component of Genesis Therapeutics' expanding portfolio of AI technologies. By combining novel deep neural networks, biophysical simulations, and highly scalable computational infrastructure, Genesis Therapeutics achieves industry-leading performance in molecular generation and property prediction.